|
FAM63B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84303999999358E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.53490000000178E-05 |
| Normal-vs-Stage2 |
6.011800E-04 |
| Normal-vs-Stage3 |
1.018180E-02 |
| Normal-vs-Stage4 |
7.319800E-02 |
| Stage1-vs-Stage2 |
7.876600E-01 |
| Stage1-vs-Stage3 |
9.784000E-01 |
| Stage1-vs-Stage4 |
8.543800E-01 |
| Stage2-vs-Stage3 |
7.894200E-01 |
| Stage2-vs-Stage4 |
9.906200E-01 |
| Stage3-vs-Stage4 |
8.558800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.1437000000033E-05 |
| Normal-vs-AfricanAmerican |
4.214300000005E-05 |
| Normal-vs-Asian |
5.46930001288359E-09 |
| Caucasian-vs-AfricanAmerican |
3.435800E-01 |
| Caucasian-vs-Asian |
1.204360E-04 |
| AfricanAmerican-vs-Asian |
3.522700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.21969999953431E-07 |
| Normal-vs-Female |
6.724200E-02 |
| Male-vs-Female |
1.474430E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.209900E-04 |
| Normal-vs-Extreme_Weight |
3.558000E-04 |
| Normal-vs-Obese |
4.050000E-04 |
| Normal-vs-Extreme_Obese |
2.301100E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.977000E-01 |
| Normal_Weight-vs-Obese |
6.048800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.204600E-01 |
| Extreme_Weight-vs-Obese |
5.956400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.474200E-01 |
| Obese-vs-Extreme_Obese |
5.404800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.969200E-04 |
| Normal-vs-Age(41-60Yrs) |
9.823300E-03 |
| Normal-vs-Age(61-80Yrs) |
3.13839999988019E-07 |
| Normal-vs-Age(81-100Yrs) |
1.39129999998655E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.743200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.317200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.433630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.173800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.623600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.862030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.28759999999495E-05 |
| Normal-VS-Type2 PRCC |
3.4826999995019E-07 |
| Normal-VS-KIRP CIMP |
2.030600E-01 |
| Normal-VS-Unclassified PRCC |
2.288400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.776830E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.136400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.351250E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.215400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.989900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.467800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.09980002882537E-09 |
| Normal-vs-N1 |
3.166000E-04 |
| Normal-vs-N2 |
4.281000E-01 |
| N0-vs-N1 |
2.398400E-01 |
| N0-vs-N2 |
6.882000E-01 |
| N1-vs-N2 |
8.377000E-01 |
|
|
